Stay informed with the latest litigation news. Explore now

Quest Diagnostics Investments competitive analysis

Latest publications and patents of Quest Diagnostics Investments New

Explore the latest publications and patents granted to Quest Diagnostics Investments, showcasing their recent innovations and technological advancements.

Last updated on: Sep 2, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Quest Diagnostics Investments

May 4, 2022System And Method For Sorting SpecimenPatent Maintained As Amended
Jan 31, 2018Methods For Detecting Estrone By Mass SpectrometryNo Opposition Filed Within Time Limit
Jan 31, 2018Thyroglobulin Quantitation By Mass SpectrometryNo Opposition Filed Within Time Limit
Jan 24, 2018Aptamers And Diagnostic Methods For Detecting The Egf ReceptorNo Opposition Filed Within Time Limit

Explore Quest Diagnostics Investments's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
May 4, 2022System And Method For Sorting Specimen1

Latest PTAB cases involving Quest Diagnostics Investments New

Discover the latest PTAB cases involving Quest Diagnostics Investments, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 8, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Quest Diagnostics Investments

IPR2019-01618Sep 17, 2019LABORATORY OF AMERICAQUEST DIAGNOSTICS INVESTMENTSTerminated-Settled
IPR2019-01517Aug 19, 2019LABORATORY OF AMERICAQUEST DIAGNOSTICS INVESTMENTSInstitution Denied
IPR2019-01425Jul 29, 2019LABORATORY OF AMERICAQUEST DIAGNOSTICS INVESTMENTSFinal Written Decision
IPR2019-00738Feb 25, 2019LABORATORY OF AMERICAQUEST DIAGNOSTICS INVESTMENTSFinal Written Decision

Top competitors of Quest Diagnostics Investments

Top competitors of Quest Diagnostics Investments based on patent oppositions.